Abstract
Adverse reaction rates to computed tomography (CT) and magnetic resonance imaging
(MRI) contrast agents are well published. However, there is no literature regarding
systems-based changes to improve contrast reaction management. As part of ongoing
quality improvement monitoring at our institution, contrast reaction events were reviewed.
Contrast reactions for CT and MRI were captured at lower rates for the inpatient setting
compared to outpatient by an order of a magnitude. The documented inpatient events
were more likely to be severe in nature. Given this discrepancy, focus is being placed
upon identifying potential barriers to capturing and appropriately managing inpatient
contrast reactions.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Incidence and severity of acute allergic-like reactions to IV nonionic iodinated contrast material in children.Am J Roentgenol. 2007; 188: 1643-1647
- Frequency and severity of acute alleric-like reactions to gadolinium-containing IV contrast media in children and adults.Am J Roentgenol. 2007; 189: 1533-1538
- Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses.Am J Roentgenol. 2009; 193: 1124-1127
- Adverse reactions to gadolinium contrast media: a review of 36 cases.Am J Roentgenol. 1996; 167: 847-849
- Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR registry.J Am Coll Cardiol Img. 2011; 4: 1171-1176
- Acute adverse reactions to magnetic resonance contrast media—gadolinium chelates.Br J Radiol. 2006; 79: 368-371
- Acute adverse reactions to gadopentate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections.Am J Roentgenol. 2010; 194: 430-434
- Extracellular gadolinium-based contrast media: an overview.Eur J Radiol. 2008; 66: 160-167
- Delayed adverse reaction to contrast-enhance CT: a prospective single-center study comparison to control group without enhancement.Radiology. 2010; 255: 764-771
- Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial.Radiology. 2006; 240: 56-64
- Trends in adverse events after IV administration of contrast media.Am J Roentgenol. 2001; 176: 1385-1388
- Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication.Am J Roentgenol. 2001; 176: 1389-1392
- Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions.Am J Roentgenol. 2008; 191: 409-415
- Incidence of immediate gadolinium contrast media reactions.Am J Roentgenol. 2011; 2: 138-143
- Immediate hypersensitivity reaction to gadolinium-based MR contrast media.Radiology. 2012; 264: 414-422
- Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology fellowship directors.Acad Radiol. 1999; 6: 656-664
- Prevalence of acute adverse reactions to gadobutrol—a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials.Eur J Radiol. 2010; 74: 186-192
Article info
Publication history
Published online: May 08, 2015
Accepted:
April 22,
2015
Received in revised form:
April 12,
2015
Received:
February 11,
2015
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
